Scarica l'app Stockscreener
2.52
3.26%
-0.085
Dopo l'orario di chiusura:
2.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZNTL Giù?
Forum
Previsione
Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zentalis Pharmaceuticals, Inc.(NasdaqGM: ZNTL) added to S&P Global BMI Index - marketscreener.com
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - 富途牛牛
Zentalis Pharmaceuticals stock gains after ovarian cancer trial update and insider buying - AD HOC NEWS
Zentalis Pharmaceuticals stock falls after public offering pricing and trades below recent highs - AD HOC NEWS
This Small Biotech’s Cancer Drug Could Reach $1.3 Billion In Peak Sales - Benzinga
William Blair Initiates Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating - Moomoo
ZNTL Initiates Coverage On by William Blair -- Rating Set to Out - GuruFocus
William Blair Initiates Zentalis Pharmaceuticals at Outperform - marketscreener.com
Zentalis at Morgan Stanley conference: azenosertib push gains shape By Investing.com - Investing.com Canada
Zentalis Pharmaceuticals, Inc. at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
Zentalis at Wells Fargo conference: azenosertib gains clearer path - Investing.com
Zentalis Pharmaceuticals stock gains as investor conferences highlight azenosertib program - ad-hoc-news.de
Zentalis to present at Wells Fargo, Morgan Stanley events | 2026-09-02 | Investing News - Stockhouse
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Four new hires get rights to buy 269,000 Zentalis shares - Stock Titan
Zentalis Pharmaceuticals: Data Due H1 '27 Will Clarify Prospects Of Azenosertib (ZNTL) - Seeking Alpha
Zentalis (ZNTL) Earnings Snapshot: EPS Does Not Reach the Reported Estimate; After Earnings: Shares Move 3.19% HigherSaaS Earnings Trends - dars.gov.et
Zentalis (ZNTL) Q2 2026 Results: Reported EPS Misses Expectations in the Available Record; Share Move: The Stock Ends Down 1.70% in the Current UpdateReturn On Capital - vinanet.vn
Zentalis (ZNTL) Results Check: The EPS Result Is Below Expectation in the Available Record; Price Reaction: The Stock Records a 0.39% Decrease in the Available RecordEarnings Turnaround - vinanet.vn
Zentalis (ZNTL) Earnings Report: EPS Does Not Reach the Reported Estimate on the Day; Stock Move: The Share Price Adds 0.52% in the Latest ReadingFiscal Year Earnings - vinanet.vn
Zentalis Pharmaceuticals(ZNTL.US) 10% Shareholder Buys US$15.17 Million in Common Stock - Moomoo
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Group Walters Buys 4,335,000 Shares of Stock - MarketBeat
Walters Group acquires $15.17 million in Zentalis Pharmaceuticals stock - Investing.com
Nearly one-fifth of Zentalis (NASDAQ: ZNTL) sits with one investor group - Stock Titan
Zentalis Pharma closes $92.6 million public offering - The Pharma Letter
Zentalis Pharmaceuticals closes $92.6 million stock offering By Investing.com - Investing.com Canada
Zentalis Pharmaceuticals closes $92.6 million stock offering - Investing.com
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Zentalis Pharmaceuticals Announces Closing of Underwritten - GlobeNewswire
GSA Capital Partners LLP Buys New Shares in Zentalis Pharmaceuticals, Inc. $ZNTL - MarketBeat
Zentalis Pharmaceuticals Closes Offering of Common Shares - Yahoo Finance
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Zentalis Pharmaceuticals Shares Fall After Pricing $80.5 Million Offering to Fund Clinical Pipeline - marketscreener.com
Latham Represents Zentalis Pharmaceuticals in US$80.5 Million Underwritten Public Offering - lw.com
symbol__ Stock Quote Price and Forecast - CNN
Why is Zentalis Pharmaceuticals stock tumbling today? By Investing.com - Investing.com Canada
Why is Zentalis Pharmaceuticals stock tumbling today? - Investing.com
Zentalis Pharmaceuticals Shares Fall on Public Offering Pricing - Moomoo
Zentalis Pharmaceuticals (ZNTL) Prices $80.5M Public Offering to Fund Clinical Trials - GuruFocus
Zentalis Pharmaceuticals Prices $80.5 Million Offering to Fund Clinical Pipeline - marketscreener.com
Zentalis Pharmaceuticals prices $80.5M stock offering at $3.50 By Investing.com - Investing.com Australia
Zentalis Pharmaceuticals prices $80.5M stock offering at $3.50 - Investing.com
Zentalis Sets $3.50 Share Price to Fund Clinical Trials - Stock Titan
Zentalis Pharmaceuticals Announces Pricing Of Underwritten Public Offering - TradingView
Barclays PLC (ZNTL) discloses 2.26M-share, 3.17% stake in Zentalis - Stock Titan
Zentalis Pharmaceuticals announces public stock offering By Investing.com - Investing.com Australia
Zentalis Pharmaceuticals announces public stock offering - Investing.com
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering - TradingView
Zentalis Pharmaceuticals stock falls on public offering news By Investing.com - Investing.com Nigeria
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):